Summary
The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is especially the case when it comes to children. Although pediatric patients comprise a smaller population of pharmaceutical consumers, they have a greater need for products given the paucity of treatment options specifically for them. This two-part paper discusses the need for collaboration across the industry to ensure children get the medicines they need. Download to read Part One or click here to read Part Two.
Register to download
Global Pediatric Drug Development Collaboration Part One
You may also be interested in:

When Volunteering is Part of Who You Are

Master Protocols Address Rarity and Patient Limitations for Pediatric Oncology Trials
A lack of suitable pediatric patients to participate in clinical trials is already an issue. With the RACE for Children Act we expect to see an…

Perspectives and Stories from the Pediatric Collaboration Team
The Center for Pediatric Clinical Development (CPCD) is comprised of 11 dedicated staff members who share diverse healthcare and research…